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Introduction: Benign lesions of the cervix such as hyperplasia, endometriosis, cervicitis and endocervical polyps are health 
concerns for women globally. Meanwhile, Cervical cancer is the fourth most common cancer among women in the world, 
with developing countries bearing the brunt of the burden in terms of morbidity and mortality. This study examines the 
histopathological pattern of cervical biopsies in a tertiary health institution in Lagos, Nigeria.
Materials and Methods: This was a retrospective study of all cervical biopsies received in a government‑owned tertiary 
health institution and a private pathology laboratory both in Ikeja over an 8‑year period. All the slides were retrieved and 
reviewed while socio‑demographic and clinical details were obtained from request and clinical notes. Data analysis was 
conducted using the Statistical Package for Social Science version 20.
Results: A total of 901 biopsies were retrieved, representing 4.8% of the total biopsies conducted. The age range of patients 
was 19–87 years with a mean age of 49 ± 13.0 years. The benign tumours accounted for 58.8% of the cases, with a benign 
to malignant ratio of 1.5:1. Squamous cell carcinoma (SCC), endocervical polyps, and cervical intraepithelial neoplasm 
accounted for 36.1%, 30.9%, and 15.1% of the total cervical biopsies, respectively. The benign tumours were statistically 
related to the younger age groups (P = 0.00), however, malignant tumours showed no relationship with age group (P = 0.325). 
Conclusion: SCC and endocervical polyps were the most common malignant and benign cervical biopsies, respectively. 
The benign tumours were seen more in the younger age group. Early detection of some of these benign conditions may 
provide an opportunity for appropriate interventions to prevent further complications.
Key words: Benign; biopsy; cervical cancer; cervical intraepithelial neoplasm; endocervical polyps; malignant; squamous 
cell carcinoma.
Introduction
The cervix is the most inferior portion of the uterus, which 
protrudes into the upper vagina.[1] Being the gateway into 
the womb, it is prone to infections and other pathological 
conditions such as cancer, hyperplasia, endometriosis, 
cervicitis, and endocervical polyps.[2] Chronic non-specific 
cervicitis is the most common inflammatory lesion with 
variable aetiological microbial agents.[3] The prevalence rate 
of cervicitis among other non-neoplastic lesions of the cervix 
in Nigeria has been reported by two separate studies to be 
59.8% and 80.0%, respectively.[4,5]
Benign lesions of the cervix are common and include 
endocervical hyperplasia, endometriosis, Nabothian cysts, 
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and endocervical polyps.[6] Nwachokor and Forae documented 
56.3% of cervical lesions as benign with a benign to malignant 
ratio of 1.3:1.[4] Other studies have also reported that 
endocervical polyps is one of the most frequent benign 
lesions in the cervix, with rates ranging between 60.0% and 
91.7%.[4,7,8]
Cervical cancer is the fourth most common cancer among 
women in the world. In 2012 alone, 528,000 new cases 
were detected globally.[1] Eighty-five percent of cervical 
cancer global burden occurs in the developing countries, and 
90% of cervical cancer deaths also occur in these regions.[1] 
Nnadi et al. studied gynaecologic malignancies in northern 
Nigeria observing that cervical cancer is the most common 
gynecological malignancy.[9]
Early diagnosis of cervical lesions is vital for the reduction 
of the burden of ill health associated with these conditions. 
Furthermore, an understanding of cervical disease pattern 
is essential for programmatic decision on how best to 
manage and plan for appropriate interventions in promoting 
maternal health. The goal of this study is to determine the 
histopathologic pattern of cervical biopsies in a private and 
a tertiary health institution in Lagos, Nigeria.
Materials and Methods
This is a retrospective study of all cervical biopsies received 
in a government-owned tertiary health institution and a 
private pathology laboratory both based in Ikeja, Lagos, 
Nigeria over an 8-year period between 1st January 2008 
and 31st December 2015. The tertiary pathology laboratory 
serves as the teaching hospital with over thirty secondary 
health care facilities in Lagos State with a population of 
over 15 million people. It also serves as a referral centre 
to patients from the contiguous states in the country. The 
private laboratory serves mainly the private hospitals in 
Ikeja area and its immediate environs. Approval for the use 
of data was obtained from the department of Pathology and 
Forensic Medicine, LASUTH, and the management of the 
private pathology laboratory.
All the formalin-fixed paraffin-embedded (FFPE) slides were 
retrieved and reviewed by first two authors. In cases of broken 
and lost slides, sections were re-cut from the block, stained 
with routine haematoxylin and eosin stains (H and E) and 
examined microscopically.
The demographic and clinical information were obtained 
from request forms, and where applicable the clinical notes 
were sought. The data were analysed using the Statistical 
Package for Social Science version 20, as presented in tables 
and figures. Chi-square was used to test the association 
between variables, and statistical significance was taken as 
P value < 0.05.
Results
A total of 901 cervical biopsies were received out of the 
total of 18745 biopsies during the period under review, 
representing 4.8% of the total biopsy received. The mean 
age was 49 ± 13.0 years with an age range of 19 to 87 years.
Most of the cervical biopsies were from patients in the 
5th decade of life, followed by patients in the 31–40 years 
age group. Most (58.8%) of the biopsies were benign with a 
benign to malignant ratio of 1.5:1 [Table 1].
Table 2 revealed that endocervical polyps accounted for 
51.1% of the total benign lesions seen and this was followed 
by cervical intraepithelial neoplasm (CIN) (24.9%). Squamous 
cell carcinoma (SCC) accounted for 36.1% of the total cervical 
biopsies studied. The others included Nabothian cysts, 
adenomyosis, and cervical prolapse among others.
Table 1: Demographic profile
Parameter Frequency Percentage
Age category (years)










Table 2: Histopathological diagnosis of cervical biopsies
Parameter Frequency Percentage Percentage 
total
Benign
Adenomyosis 8 1.5 0.9
Cervicitis 91 17.2 10.4
Cervical intraepithelial neoplasia (CIN) 132 24.9 15.1
Granular cell tumour 3 0.6 0.3
Endocervical/leiomyomatous polyp 271 51.1 30.9
Others 25 4.7 2.8
Total 530 100.0
Malignant
Adenocarcinoma 20 5.8 2.3
Poorly-differentiated carcinoma 7 2.0 0.8
Squamous cell carcinoma (SCC) 317 92.2 36.1
Total 344 100.0 100.0
874
Faduyile, et al.: Histopathological study of cervical biopsies
126 Tropical Journal of Obstetrics and Gynaecology / Volume 34 / Issue 2 / May-August 2017
CIN accounted for approximately half of all premalignant 
lesions (46.2%) and only about one-fifth of CIN were in the high 
grade. Most of the SCC was well-differentiated (keratinising) 
as against only a quarter non-keratinising [Table 3].
There was a steady rise in the proportion of malignant 
lesions compared to benign lesions until it became the 
predominant diagnosis from the 6th decade of life. The 
classification (benign or malignant) in relation to patient age 
was statistically significant [Figure 1].
Most of the benign tumours and inflammatory conditions 
occurred in the 4th and 5th decade of life and there was a 
decline from the 6th decade of life. A statistically significant 
association was also observed between the diagnosis of 
benign tumours and patients’ age [Table 4].
There was a similarity in the proportion of SCC within 
the age groups with the 7th decade being the highest. 
Adenocarcinoma was most common in the 6th decade 
followed by the 5th decade. There was, however, no significant 
association between the age and the time/decade of diagnosis 
of malignancy [Table 5].
Discussion
The proportion of cervical biopsies to the total biopsies of 
4.8% observed in this study is slightly higher than the 3% 











Table 4: Cross-tabulation of benign lesions against age groups
Age (years) Benign types (%) Total
Adenomyosis Cervicitis CIN Granular cell tumour Endocervical polyp Others
30 and below 3 (37.5%) 5 (5.5%) 3 (2.3%) - 17 (5.7%) - 28 (5.3%)
31-40 3 (37.5%) 29 (31.9%) 48 (36.4%) 3 (100.0%) 124 (41.2%) 2 (8.0%) 178 (33.6%)
41-50 2 (25.0%) 37 (40.7%) 60 (45.5%) - 94 (31.2%) 10 (40.0%) 204 (38.5%)
51-60 - 15 (16.5%) 12 (9.1%) - 55 (18.3%) 6 (24.0%) 88 (16.6%)
61-70 - 3 (3.3%) 6 (4.5%) - 11 (3.6%) 7 (28.0%) 27 (5.1%)
Above 70 - 2 (2.2%) 2 (2.3%) - - - 5 (0.9%)
Total 8 (100.0%) 91 (100.0%) 132 (100.0%) 3 (100.0%) 301 (100.0%) 25 (100.0%) 530 (100.0%)
P=0.000
Table 5: Cross tabulation of malignant tumour against age groups
Age (years) Malignant type (%) Total
Adenocarcinoma Poorly-differentiated carcinoma Squamous cell carcinoma
30 and below - - 3 (0.9%) 3 (0.9%)
31-40 2 (10.0%) - 64 (20.2%) 66 (19.2%)
41-50 6 (30.0%) 2 (28.6%) 68 (21.5%) 76 (22.1%)
51–60 7 (35.0%) - 65 (20.5%) 72 (20.9%)
61-70 3 (15.0%) 2 (28.6%) 71 (22.4%) 76 (22.1%)
Above 70 2 (10.0%) 3 (42.8%) 46 (14.5%) 51 (14.8%)

























31 - 40 41 - 50 51 - 60 61 - 70 Above 70
Benign %
Malignant %
Figure 1: Graph showing the diagnosis in rela  on with the age group
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seen by Omoniyi-Esan et al. in a similar study conducted in 
south-west Nigeria.[5] The benign to malignant tumour ratio 
of 1.5:1 seen in this study is consistent with other related 
studies, which have reported preponderance of benign 
tumours and ratio of 1.3:1.[4,10]
Among benign cases, endocervical polyp was the most 
common diagnosis, which represented over one-half of 
the total benign diagnosis and 31% of the total cervical 
biopsies received. The preponderance of endocervical 
polyp among the benign lesions is in consonance with 
other studies with rates varying from 60.0% to 91.7%.[4,7] 
This may also be related to the higher prevalence of 
leiomyoma among women of African decent. Cervicitis, 
an inflammatory disease comprising acute cervicitis and 
chronic non-specific cervicitis, accounted for a quarter of 
all benign tumours and 10% of all cervical biopsies received 
in this study. Most cases of cervicitis are often due to 
non-specific causes or infective agents.[4] Omoniyi-Esan 
et al. in a study on non-neoplastic diseases of the cervix 
showed a prevalence rate of 82% of chronic non-specific 
cervicitis out of 37.5% of all cervical surgical biopsies.[5] The 
higher prevalence rate in that study may be as a result of 
the addition of other tumours apart from the inflammatory 
cases.[5] This study also showed a drop in the diagnosis of 
benign diseases with advancing age of the patients, which 
was statistically significant.
CIN, which is a premalignant lesion, was seen in 15% of all 
cervical biopsies received with the prevalence of CIN 1, 2, 
and 3 of 46.2%, 32.6% and 21.2% respectively. There was a 
reduction in the prevalence of CIN from the low-grade CIN 
to high-grade CIN. The mean age of patients with the low 
grade CINs (1 and 2) was 44 ± 10 years whereas the mean 
age of CIN 3 was 48 ± 9 years. These findings are believed to 
be because of the higher rate of human papilloma virus (HPV) 
infections, the causative agents of CIN, in the younger age 
group and the clearing of the infection in the older age 
group.[11] The lower prevalence of the higher grade of CIN can 
also be explained by the body’s natural immune response in 
clearing such infections.[11]
Among the malignant tumours, SCC accounted for 92.2% and 
was also the most common diagnosis (36%) of all cervical 
surgical biopsies in this study. Several Nigerian studies 
showed an SCC prevalence rate between 88.0% and 93.9% 
among malignant tumours.[12-15] This high rate of SCC in 
Nigeria could reflect the low uptake of the Pap test and 
other screening measures such as visual inspection with 
acetic acid (VIA) capable of identifying dysplastic conditions 
before transformation to malignancy. SCC of the cervix has 
been reduced drastically in many developed countries as a 
result of organised cervical screening with Pap test and HPV 
vaccination.[16]
Most of the SCC (81.4%) in this study were well 
differentiated (keratinising) as against the non-keratinising 
variants. Similar studies by Adelusi et al. from Ibadan and 
Adeniji from Ilorin found a well-differentiated SCC prevalence 
of approximately 60.1%.[15,16] This finding is, however, at 
variance with that of Abdus-salam who reported that 53.4% of 
the SCC tumours were poorly differentiated, 14% moderately 
differentiated, and 32.6% well differentiated.[12] Adeniji also 
observed that patients above the age of 45 years had well 
differentiated SCC.[17] Although the various methods of 
histologic grading have not been found to have any significant 
impact on prognosis.[18,19]
Olu-Eddo et al. also found an age range for cervical cancer as 
15–90 years with a mean age of 50.4 years (SD ± 13.5) and 
a peak occurrence in the 5th decade.[13] Adeniji reported an 
age range of 23–85 years with peak age at 5th and 7th decade 
and average age of 51.8 years.[17] This study, however, 
showed a fairly equal distribution of SCC from the 3rd to the 
7th decade, with a mean age of 55 ± 14 years and age range 
of 24–87 years, which is closely related to the observation 
of Adeniji and Olu Eddo et al.[13,17]
Adenocarcinoma and poorly-differentiated (unclassified) 
carcinoma were 5.8% and 2.0%, respectively, of the total 
malignant diagnosis. The low prevalence of adenocarcinoma 
seen in this study is consistent with other studies in Nigeria 
which range between 2.4% and 12%.[12-15,17]
We also found out that, with advancing age, the rate of cancer 
diagnosis increased and it became the dominant diagnosis of 
cervical biopsies from the 6th decade of life, although there 
was no statistical significance between the age of patients 
and diagnosis of malignancy. However, there was a statistical 
significant relationship between the diagnosis of benign 
tumours and age of patients. The diagnosis of benign tumours 
reduced with advancing age.
The limitation of this study being a retrospective one 
includes our inability to extract details like if the tumours 
were diagnosed by screening or by symptoms, presence or 
absence of patient’s co-morbidities, our inability to properly 
follow up the CINs to determine if there was progression or 
retrogression of the disease amongst others.
Conclusion
SCC was the most common diagnosis of cervical biopsies and 
were mainly well-differentiated type. Endocervical polyp was 
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the most common benign tumour in cervical biopsies. The 
age of patients was statistically significant with the diagnosis 
of benign diseases but not with malignant conditions. 
Cervical biopsies from the 6th decade of life are more likely 
malignant. Early detection of some of these benign conditions 
may provide an opportunity for appropriate interventions 
to prevent further complications such as progression from 
benign to malignant conditions.
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